ArticleClinical cancer research : an official journal of the American Association for Cancer Research2012

The HSP90 inhibitor XL888 overcomes BRAF inhibitor resistance mediated through diverse mechanisms.

Kim H T Paraiso et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.